CVS Health Corp. (CVS)

I'm all in favor of mergers and acquisitions -- the more we get, the higher the stock market goes -- but I am not in favor of making conclusions based on tips about deals.

I like the name, and I like the progress that CVS is making. This stock can go higher.

Even before reporting better-than-expected third-quarter results, the pharmacy giant was seeing more aggressive buying of its shares.

OPEC forecasts declining demand for OPEC oil, not a decline in global demand. That distinction is key.

Disney, Qualcomm and Square are among 75 key reports we are watching.

Charts and indicators agree with Jim Cramer's bullish year-end call.

There are plenty of senior growth companies that can still move higher.

RMPIA is up 20.9% in the first nine months of 2019.

When you have an oversold market you've got a true coiled spring that can rally beyond where it might ordinary go on good news.

So many companies -- like Netflix, Facebook and Johnson & Johnson -- are not trading on earnings per share, but on factors that are nearly impossible to quantify.

The company appears to be combating the risk of possible cost-cutting reform with their continued diversification.

Following its Aetna acquisition that closed back in November, CVS is positioning itself for further strength.

CVS continues to move in the right direction for the bulls.

Let's check out the charts.

Gains in Amgen, CVS, and others helped offset declines in other stocks, as the RMPIA rose over the last two months to 0.6%, handily beating all the major domestic stock market averages.

Agency has the authority to carve out an exception to existing laws.

LYFT's earnings beat appears to be giving hope to Uber investors in advance of its own report later Thursday, but the two rivals have key strengths to watch, such as Lyft's U.S. focus and Uber's move on food delivery.

Lower rates are terrible unless you spend money, buy goods, create businesses, refinance loans and basically exist in America.

The Chinese government has now demonstrated an ability to control the S&P 500, even at the risk of Chinese domestic capital flight.

In July, the RMPIA climbed 0.6%, bringing its year-to-date return to just over 21%.

Be sure your cannabis investments have the right CBD strategy, as the market for these products takes off.

This matters: Why the sudden 'weakness' across European debt markets?

I am neutral on this market, and only a cool off of the hottest stocks can justify a further advance.

By selling out of big losers prior to the quarter's close, portfolio managers can hide the stocks from clients, but some downtrodden shares could be ripe for bounces next week, so here's my list.

CVS and Walgreens Boots Alliance make for good buys.

Amid May's market turbulence, the RMPIA was buoyed by the more than 4% rise from Medtronic.

A look at the charts and indicators of three big names in the sector .

Insider buying by corporate officers should be taken as optimistic visions of the future prospects of their companies and their stock prices.